Beauty Health Management
Management criteria checks 1/4
Beauty Health's CEO is Marla Beck, appointed in Nov 2023, has a tenure of 1.08 years. total yearly compensation is $2.31M, comprised of 8% salary and 92% bonuses, including company stock and options. directly owns 0.057% of the company’s shares, worth $99.00K. The average tenure of the management team and the board of directors is 1.2 years and 3.6 years respectively.
Key information
Marla Beck
Chief executive officer
US$2.3m
Total compensation
| CEO salary percentage | 8.0% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.06% |
| Management average tenure | 1.2yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Health Check: How Prudently Does Beauty Health (NASDAQ:SKIN) Use Debt?
Oct 18
Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump
Aug 06Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?
Jul 16Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%
Jun 14Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)
May 30The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company
Feb 16The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion
Jun 19Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?
May 28At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?
Apr 04Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality
Mar 08What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?
Jan 01An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued
Dec 05The Beauty Health Company: A Compelling Mid To Long-Term Growth Story
Oct 12Beauty-Health Company announces $200M buyback program
Sep 27The Beauty Health Q2 2022 Earnings Preview
Aug 08The Beauty Health Company: Not Looking The Best
Jul 30Beauty Health: Skincare Today And Alpha Tomorrow
May 13CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$28m |
| Jun 30 2024 | n/a | n/a | -US$84m |
| Mar 31 2024 | n/a | n/a | -US$81m |
| Dec 31 2023 | US$2m | US$185k | -US$100m |
| Sep 30 2023 | n/a | n/a | -US$84m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$7m |
| Dec 31 2022 | US$175k | n/a | US$44m |
Compensation vs Market: Marla's total compensation ($USD2.31M) is above average for companies of similar size in the US market ($USD1.38M).
Compensation vs Earnings: Marla's compensation has increased whilst the company is unprofitable.
CEO
Marla Beck (54 yo)
1.1yrs
Tenure
US$2,308,461
Compensation
Ms. Marla Malcolm Beck serves as Member of Board of Advisors of Glowbar, Inc. since January 2023. She is Director at GLO Pharma, Inc. since September 7, 2022. She was an Independent Director of The Beauty...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.1yrs | US$2.31m | 0.057% $ 99.0k | |
| Chief Financial Officer | 1.3yrs | US$3.26m | 0.12% $ 217.9k | |
| Advisor | less than a year | US$3.01m | 0.23% $ 408.3k | |
| Chief Supply Chain & Operations Officer | less than a year | no data | no data | |
| VP & General Counsel | 4.1yrs | no data | no data | |
| Chief Marketing Officer | less than a year | no data | no data | |
| Chief Human Resources Officer | 1.9yrs | no data | no data | |
| President of APAC | 3.3yrs | no data | no data | |
| President of EMEA | 2.3yrs | no data | no data | |
| Chief Revenue Officer | less than a year | no data | no data |
1.2yrs
Average Tenure
58yo
Average Age
Experienced Management: SKIN's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 2.5yrs | US$2.31m | 0.057% $ 99.0k | |
| Independent Director | 3.6yrs | US$207.49k | 0.074% $ 128.9k | |
| Independent Director | 3.6yrs | US$214.99k | 0.16% $ 278.6k | |
| Director | no data | no data | no data | |
| Independent Director | 3.6yrs | US$219.99k | 0.052% $ 90.9k | |
| Chairman | 3.6yrs | US$353.24k | 6.92% $ 12.1m | |
| Independent Director | 3.5yrs | US$202.49k | 0.033% $ 57.8k | |
| Independent Director | 3.6yrs | US$219.99k | 0.031% $ 53.9k |
3.6yrs
Average Tenure
58.5yo
Average Age
Experienced Board: SKIN's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 12:47 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Beauty Health Company is covered by 15 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bruce Jackson | Benchmark Company |
| Navann Ty Dietschi | BNP Paribas Exane |
| Kyle Rose | Canaccord Genuity |